Next Article in Journal
Phase I/Ib Study of Tenalisib (RP6530), a Dual PI3K δ/γ Inhibitor in Patients with Relapsed/Refractory T-Cell Lymphoma
Next Article in Special Issue
Murine Models of Myelofibrosis
Previous Article in Journal / Special Issue
Myelomonocytic Skewing In Vitro Discriminates Subgroups of Patients with Myelofibrosis with A Different Phenotype, A Different Mutational Profile and Different Prognosis
 
 
Article

Article Versions Notes

Cancers 2020, 12(8), 2292; https://doi.org/10.3390/cancers12082292
Action Date Notes Link
article pdf uploaded. 14 August 2020 16:42 CEST Version of Record https://www.mdpi.com/2072-6694/12/8/2292/pdf-vor
article supplementary file uploaded. 14 August 2020 16:42 CEST - https://www.mdpi.com/2072-6694/12/8/2292#supplementary
article xml file uploaded 15 August 2020 14:14 CEST Original file -
article xml uploaded. 15 August 2020 14:14 CEST Update https://www.mdpi.com/2072-6694/12/8/2292/xml
article pdf uploaded. 15 August 2020 14:14 CEST Updated version of record https://www.mdpi.com/2072-6694/12/8/2292/pdf
article html file updated 15 August 2020 14:15 CEST Original file -
article html file updated 22 July 2022 03:37 CEST Update https://www.mdpi.com/2072-6694/12/8/2292/html
Back to TopTop